Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pernix Theraptcs (PTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 34,416
  • Shares Outstanding, K 11,120
  • Annual Sales, $ 140,860 K
  • Annual Income, $ -169,590 K
  • 36-Month Beta 1.69
  • Price/Sales 0.25
  • Price/Cash Flow 0.00
  • Price/Book 0.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.87 +7.67%
on 07/26/17
5.18 -40.35%
on 07/14/17
-1.18 (-27.63%)
since 06/27/17
3-Month
2.87 +7.67%
on 07/26/17
7.15 -56.78%
on 05/10/17
-1.02 (-24.82%)
since 04/27/17
52-Week
1.83 +68.85%
on 12/28/16
10.40 -70.29%
on 08/03/16
-2.81 (-47.63%)
since 07/27/16

Most Recent Stories

More News
Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced financial results for the three and six months ended June 30, 2017.

PTX : 3.09 (-1.90%)
Investor Network: Pernix Therapeutics Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) will be discussing their earnings results in their Q2 Earnings Call to be held July 27, 2017 at 4:30 PM Eastern...

PTX : 3.09 (-1.90%)
Platinex Joins Forces With FMI Capital Advisory Inc. to Pursue Transactions in the Cannabis Space

TORONTO, ONTARIO--(Marketwired - July 25, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") has engaged FMI Capital Advisory Inc. ("FMI") as financial advisor to assist...

PTX : 3.09 (-1.90%)
PTX.CN : 0.090 (+12.50%)
PANXF : 0.0556 (-8.85%)
Platinex Announces Expiry of Letter of Intent

TORONTO, ONTARIO--(Marketwired - July 21, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) (the "Company" or "Platinex") announces that the forty five day period set out in a Letter of Intent with...

PTX : 3.09 (-1.90%)
PTX.CN : 0.090 (+12.50%)
PANXF : 0.0556 (-8.85%)
Pernix Commences Refinancing Transactions to Fortify Balance Sheet

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today commenced a series of refinancing transactions intended to improve liquidity, extend...

PTX : 3.09 (-1.90%)
Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced certain preliminary unaudited financial results for the second quarter ended...

PTX : 3.09 (-1.90%)
Platinex Announces New Website Launch & Results of Warrant Exercise

TORONTO, ONTARIO--(Marketwired - June 29, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") announces the launch of their brand new community resource website, on Saturday,...

PTX : 3.09 (-1.90%)
PTX.CN : 0.090 (+12.50%)
PANXF : 0.0556 (-8.85%)
Platinex Announces New Website Launch & Results of Warrant Exercise

TORONTO, ONTARIO--(Marketwired - June 29, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") announces the launch of their brand new community resource website, on Saturday,...

PTX : 3.09 (-1.90%)
PTX.CN : 0.090 (+12.50%)
PANXF : 0.0556 (-8.85%)
Platinex Completes Expansion of Shining Tree Holdings

TORONTO, ONTARIO--(Marketwired - June 21, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) (the "Company") has agreed to purchase 127 claim units totaling 2,032 hectares (5,080 acres) in the Shining...

PTX : 3.09 (-1.90%)
PTX.CN : 0.090 (+12.50%)
PANXF : 0.0556 (-8.85%)
IAG : 5.11 (-2.67%)
Platinex Completes Expansion of Shining Tree Holdings

TORONTO, ONTARIO--(Marketwired - June 21, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) (the "Company") has agreed to purchase 127 claim units totaling 2,032 hectares (5,080 acres) in the Shining...

PTX : 3.09 (-1.90%)
PTX.CN : 0.090 (+12.50%)
PANXF : 0.0556 (-8.85%)
IAG : 5.11 (-2.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Pernix Therapeutics Holdings Inc., formerly known as Golf Trust of America, Inc., is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to meet medical needs primarily in pediatrics. The Company's product families include Aldex, Pediatex, Z-Cof, Brovex,...

See More

Support & Resistance

2nd Resistance Point 3.34
1st Resistance Point 3.21
Last Price 3.09
1st Support Level 3.01
2nd Support Level 2.94

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.